{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T21:48:47Z","timestamp":1793742527921,"version":"4.6.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.ygyno.2015.09.078","type":"journal-article","created":{"date-parts":[[2015,10,3]],"date-time":"2015-10-03T05:07:20Z","timestamp":1443848840000},"page":"424-428","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"title":["Prognostic factors of oncological and reproductive outcomes in fertility-sparing treatment of complex atypical hyperplasia and low-grade endometrial cancer using oral progestin in Chinese patients"],"prefix":"10.1016","volume":"139","author":[{"given":"Rong","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianliu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yali","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shijun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihui","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2015.09.078_bb0005","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3802\/jgo.2009.20.2.67","article-title":"Current status of gynecologic cancer in Japan","volume":"20","author":"Ushijima","year":"2009","journal-title":"J. Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.09.078_bb0010","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3802\/jgo.2010.21.3.151","article-title":"Current status in the management of uterine corpus cancer in Korea","volume":"21","author":"Jeong","year":"2010","journal-title":"J. Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.09.078_bb0015","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/1097-0142(19850715)56:2<403::AID-CNCR2820560233>3.0.CO;2-X","article-title":"The behavior of endometrial hyperplasia. A long-term study of \u201cuntreated\u201d hyperplasia in 170 patients","volume":"56","author":"Kurman","year":"1985","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2015.09.078_bb0020","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/01.AOG.0000154151.14516.f7","article-title":"Risk factors for young premenopausal women with endometrial cancer","volume":"105","author":"Soliman","year":"2005","journal-title":"Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.ygyno.2015.09.078_bb0025","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.bpobgyn.2008.11.010","article-title":"Anovulation with or without PCO, hyperandrogenaemia and hyperinsulinaemia as promoters of endometrial and breast cancer","volume":"24","author":"Papaioannou","year":"2010","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"issue":"11","key":"10.1016\/j.ygyno.2015.09.078_bb0030","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1002\/cncr.21866","article-title":"Association between adiponectin, insulin resistance, and endometrial cancer","volume":"106","author":"Soliman","year":"2006","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.ygyno.2015.09.078_bb0035","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/OGX.0b013e31822f8f66","article-title":"Fertility-sparing management of endometrial adenocarcinoma","volume":"66","author":"Dorais","year":"2011","journal-title":"Obstet. Gynecol. Surv."},{"key":"10.1016\/j.ygyno.2015.09.078_bb0040","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1471-0528.2004.00398.x","article-title":"Outcome of fertility-preserving treatment in young women with endometrial carcinomas","volume":"112","author":"Niwa","year":"2005","journal-title":"BJOG"},{"key":"10.1016\/j.ygyno.2015.09.078_bb0045","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.fertnstert.2009.07.999","article-title":"Outcomes of conservative therapy for young women with early endometrial adenocarcinoma","volume":"93","author":"Mao","year":"2010","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.ygyno.2015.09.078_bb0050","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s12094-008-0173-1","article-title":"Conservative management of patients with early endometrial carcinoma: a systematic review","volume":"10","author":"Chiva de Agustin","year":"2008","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.ygyno.2015.09.078_bb0055","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00404-011-1959-x","article-title":"Effectiveness of high-dose progestin and long-term outcomes in young women with early-stage, well-differentiated endometrioid adenocarcinoma of uterine endometrium","volume":"285","author":"Park","year":"2012","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.ygyno.2015.09.078_bb0060","first-page":"1037","article-title":"Progestin treatment of atypical hyperplasia and well-differentiated adenocarcinoma of the endometrium to preserve fertility","volume":"32","author":"Koskas","year":"2012","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ygyno.2015.09.078_bb0065","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.ygyno.2013.11.021","article-title":"Metformin is associated with improved survival in endometrial cancer","volume":"132","author":"Ko","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.09.078_bb0070","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ygyno.2013.10.026","article-title":"Metformin use and endometrial cancer survival","volume":"132","author":"Nevadunsky","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.09.078_bb0075","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2337\/dc11-1313","article-title":"Mortality after incident cancer in people with and without type 2 diabetes: impact of metformin on survival","volume":"35","author":"Currie","year":"2012","journal-title":"Diabetes Care"},{"issue":"3\u20135","key":"10.1016\/j.ygyno.2015.09.078_bb0080","first-page":"113","article-title":"Metformin promotes progesterone receptor expression via inhibition of mammalian target of rapamycin (mTOR) in endometrial cancer cells","volume":"126","author":"Wang","year":"2011","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.ygyno.2015.09.078_bb0085","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0304-3835(01)00462-1","article-title":"Conservative therapy for adenocarcinoma and atypical endometrial hyperplasia of the endometrium in young women: central pathologic review and treatment outcome","volume":"167","author":"Kaku","year":"2001","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ygyno.2015.09.078_bb0090","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/(SICI)1097-0142(19970115)79:2<320::AID-CNCR15>3.0.CO;2-2","article-title":"Progestin alone as primary treatment of endometrial carcinoma in premenopausal women. Report of seven cases and review of the literature","volume":"79","author":"Kim","year":"1997","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2015.09.078_bb0095","first-page":"1037","article-title":"Progestin treatment of atypical hyperplasia and well-differentiated adenocarcinoma of the endometrium to preserve fertility","volume":"32","author":"Koskas","year":"2012","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ygyno.2015.09.078_bb0100","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0029-7844(97)00297-4","article-title":"Progestin treatment of atypical hyperplasia and well differentiated carcinoma of the endometrium in women under age 40","volume":"90","author":"Randall","year":"1997","journal-title":"Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.ygyno.2015.09.078_bb0105","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ygyno.2014.02.020","article-title":"Fertility sparing treatment of complex atypical hyperplasia and lowgrade endometrial cancer using oral progestin","volume":"133","author":"Simpson","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.09.078_bb0110","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1200\/JCO.2006.08.8344","article-title":"Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial oma and atypical hyperplasia in young women","volume":"25","author":"Ushijima","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2015.09.078_bb0115","article-title":"Hysteroscopic resection in fertility-sparing surgery for atypical hyperplasia and endometrial cancer: safety and efficacy","author":"De Marzi","year":"2015","journal-title":"J. Minim. Invasive Gynecol."},{"key":"10.1016\/j.ygyno.2015.09.078_bb0120","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1048-891x.2004.014220.x","article-title":"Risk of progression in complex and atypical endometrial hyperplasia: clinicopathologic analysis in cases with and without progestogen treatment","volume":"14","author":"Horn","year":"2004","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2015.09.078_bb0125","first-page":"365","article-title":"Treatment for complex atypical hyperplasia of the endometrium","volume":"22","author":"Jobo","year":"2001","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.09.078_bb0130","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1525-1438.2007.00958.x","article-title":"Loss of phosphatase and tensin homologue deleted on chromosome 10 and phosphorylation of mammalian target of rapamycin are associated with progesterone refractory endometrial hyperplasia","volume":"18","author":"Milam","year":"2008","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2015.09.078_bb0135","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0090-8258(02)00008-2","article-title":"Mechanisms involved in the evolution of progestin resistance in human endometrial hyperplasia\u2014precursor of endometrial cancer","volume":"88","author":"Wang","year":"2003","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2015.09.078_bb0140","first-page":"403","article-title":"Choric anovulation syndrome and associated neoplasia","volume":"61","author":"Coulam","year":"1983","journal-title":"Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.ygyno.2015.09.078_bb0145","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0002-9378(16)37277-5","article-title":"The stein\u2013leventhal syndrome: analysis of 43 cases with special reference to association with endometrial carcinoma","volume":"73","author":"Dockerty","year":"1957","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.ygyno.2015.09.078_bb0150","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1055\/s-2007-992926","article-title":"Polycystic ovarian syndrome and endometrial cancer","volume":"26","author":"Navaratnarajah","year":"2008","journal-title":"Semin. Reprod. Med."},{"issue":"5","key":"10.1016\/j.ygyno.2015.09.078_bb0155","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1093\/humrep\/des042","article-title":"Evaluating the association between endometrial cancer and polycystic ovary syndrome","volume":"27","author":"Haoula","year":"2012","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.ygyno.2015.09.078_bb0160","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S1472-6483(10)61821-4","article-title":"Clomiphene citrate and ovulation induction","volume":"4","author":"Sovino","year":"2002","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.ygyno.2015.09.078_bb0165","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/aje\/kwi084","article-title":"Uterine cancer after use of clomiphene citrate to induce ovulation","volume":"161","author":"Althuis","year":"2005","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.ygyno.2015.09.078_bb0170","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1038\/sj.bjc.6605086","article-title":"Ovulation-stimulation drugs and cancer risks: a longterm follow-up of a British cohort","volume":"100","author":"Silva Idos","year":"2009","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ygyno.2015.09.078_bb0175","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1093\/aje\/kwp290","article-title":"Use of fertility drugs and risk of uterine cancer: results from a large Danish population-based cohort study","volume":"170","author":"Jensen","year":"2009","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.ygyno.2015.09.078_bb0180","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0015-0282(01)02986-7","article-title":"Cancer incidence in a cohort of infertile women who underwent in vitro fertilization","volume":"77","author":"Dor","year":"2002","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.ygyno.2015.09.078_bb0185","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ajog.2012.08.011","article-title":"Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: a systematic review and metaanalysis","volume":"207","author":"Gallos","year":"2012","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2015.09.078_bb0190","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/AOG.0b013e31827a0643","article-title":"Pregnancy outcomes after fertility-sparing management in young women with early endometrial cancer","volume":"121","author":"Park","year":"2013","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2015.09.078_bb0195","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.fertnstert.2013.11.028","article-title":"Prognostic factors of oncologic and reproductive outcomes in fertility-sparing management of endometrial atypical hyperplasia and adenocarcinoma: systematic review and meta-analysis","volume":"101","author":"Koskas","year":"2014","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.ygyno.2015.09.078_bb0200","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1097\/AOG.0b013e31828cb563","article-title":"Prediction of regression and relapse of endometrial hyperplasia with conservative therapy","volume":"121","author":"Gallos","year":"2013","journal-title":"Obstet. Gynecol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825815301396?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825815301396?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T23:30:17Z","timestamp":1537313417000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825815301396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0090825815301396"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2015.09.078","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic factors of oncological and reproductive outcomes in fertility-sparing treatment of complex atypical hyperplasia and low-grade endometrial cancer using oral progestin in Chinese patients","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2015.09.078","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}